SEARCH

SEARCH BY CITATION

References

  • 1
    Yumita N, Nishigaki R, Umemura K, Umemura S. Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound. Jpn J Cancer Res 1989; 80: 21922.
  • 2
    Yumita N, Nishigaki R, Umemura K, Umemura S. Synergetic effect of ultrasound and hematoporphyrin on sarcoma 180. Jpn J Cancer Res 1990; 81: 3048.
  • 3
    Umemura S, Yumita N, Nishigaki R. Enhancement of ultrasonically induced cell damage by a gallium-porphyrin complex, ATX-70. Jpn J Cancer Res 1993; 84: 5828.
  • 4
    Umemura S, Yumita N, Nishigaki R, Umemura S. Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn J Cancer Res 1990; 81: 9626.
  • 5
    Yumita N, Umemura S, Nishigaki R. Ultrasonically induced cell damage enhanced by photofrin II: mechanism of sonodynamic activation. In Vivo 2000; 14: 4259.
  • 6
    Yumita N, Nishigaki R, Umemura S. Sonodynamically induced antitumor effect of photofrin II on colon 26 carcinoma. Cancer Res Clin Oncol 2000; 126: 6016.
  • 7
    Yumita N, Sasaki K, Umemura S, Nishigaki R. Sonodynamically induced antitumor effect of a gallium-porphyrin complex, ATX-70. Jpn J Cancer Res 1996; 87: 3106.
  • 8
    Umemura K, Yumita N, Nishigaki R, Umemura S. Sonodynamically induced antitumor effect of pheophorbide a. Cancer Lett 1996; 102: 1517.
  • 9
    Yumita N, Nishigaki R, Sakata I, Nakajima S, Umemura S. Sonodynamically induced antitumor effect of 4-formyloximethylidene-3-hydroxy-2-vinyl-deu-terio-porphynyl(IX)-6,7-diaspartic acid (ATX-S10) Jpn J Cancer Res 2000; 91: 25560.
  • 10
    Yumita N, Umemura S. Sonodynamic therapy with photofrin II on AH130 solid tumor. Pharmacokinetics, tissue distribution and sonodynamic antitu-moral efficacy of photofrin II. Cancer Chemother Pharmacol 2003; 51: 1748.
  • 11
    Abe H, Kuroki M, Tachibana K, Li T, Awasthi A, Ueno A, Matsumoto H, Imakiire T, Yamauchi Y, Yamada H, Ariyoshi A, Kuroki M. Targeted sonodynamic therapy of cancer using a photosensitizer conjugated with antibody against carcinoembryonic antigen. Anticancer Res 2002; 22: 157580.
  • 12
    Jin ZH, Miyoshi N, Ishiguro K, Umemura S, Kawabata K, Yumita N, Sakata I, Takaoka K, Udagawa T, Nakajima S, Tajiri H, Ueda K, Fukuda M, Kumakiri M. Combination effect of photodynamic and sonodynamic therapy on experimental skin squamous cell carcinoma in C3H/HeN mice. J Derma-tol 2000; 27: 294306.
  • 13
    Agarwal R, Athar M, Elmets CA, Bickers DR, Mukhtar H. Photodynamic therapy of chemically- and ultraviolet B radiation-induced murine skin papil-lomas by chloroaluminum phthalocyanine tetrasulfonate. Photochem Photo-biol 1992; 56: 4350.
  • 14
    Brueggemeier RW, Li PK. Effects of the aromatase inhibitor 7 alpha-(4′-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)an-thracene-induced mammary carcinoma in rats. Cancer Res 1988; 48: 680810.
  • 15
    Okuyama N, Sasamoto S, Kato N, Takagi K, Yamazaki S, Tsujimoto S, Yumita N, Nishigaki R, Sasaki K, Umemura S. The effect of sonodynamic therapy on rat mammary cancer. J Med Ultrasonics 2000; 27: 14659 (in Japanese).
  • 16
    Bellnier DA, Ho YK, Panday RK, Missert JR, Dougherty TJ. Distribution and elimination of Photofrin II in mice. Photochem Photobiol 1989; 50: 2218.
  • 17
    Dougherty TJ. Photodynamic therapy. Photochem. Photobiol 1993; 58: 895905.
  • 18
    Kessel D. Porphyrin-lipoprotein association as a factor in porphyrin loacati- zation. Cancer Lett 1986; 33: 1838.
  • 19
    Takagi H, Harada Y, Misawa N, Inomata N, Liem Teresa, IIse D. Acute and subchronic toxicities of porfimer sodium (Photofrin II) in mice, rats and dog. Pharmacometrics 1995; 4: 43955.
  • 20
    Tachibana K, Uchida T, Hisano S, Morioka E. Eliminating adult T-cell leukaemia cells with ultrasound. Lancet 1997; 349: 9048.
  • 21
    Tachibana K, Sugata K, Meng J, Okamura M, Tachibana S. Liver tissue damage by ultrasound in combination with photosensitizing drug, photofrin II. Cancer Lett 1994; 78: 17781.